Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Genscript Biotech Corporation
  6. Summary
    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
32.25 28.95 32.4 34.2 34.1 Last
36535980 24756230 24773450 19077600 9471500 Volume
-11.28% -10.23% +11.92% +5.56% -0.29% Change
Estimated financial data (e) (USD)
Sales 2021 472 M - -
Net income 2021 -174 M - -
Net cash position 2021 511 M - -
P/E ratio 2021 -46,7x
Yield 2021 -
Sales 2022 744 M - -
Net income 2022 -113 M - -
Net cash position 2022 174 M - -
P/E ratio 2022 -63,4x
Yield 2022 -
Capitalization 9 200 M 9 200 M -
EV / Sales 2021 18,4x
EV / Sales 2022 12,1x
Nbr of Employees 4 597
Free-Float 61,3%
More Financials
Company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell... 
More about the company
Ratings of Genscript Biotech Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about GENSCRIPT BIOTECH CORPORATION
07/28Genscript Biotech Corporation Announces Notice of Allowance for U.S. Patent A..
CI
07/13GENSCRIPT : to Host Gene & Cell Engineering Virtual Summit
PR
07/01GENSCRIPT BIOTECH : Bio's Nasdaq-Listed Unit Files Shelf Registration in US; Sha..
MT
06/23GENSCRIPT BIOTECH : Unit Sets Up Cellular Therapy Manufacturing Facility in Belg..
MT
06/21Duke-NUS Medical School and GenScript Biotech Corporation Announce Notice of ..
CI
06/21GENSCRIPT BIOTECH : Duke-NUS and GenScript Announce Notice of Allowance for U.S...
PU
06/13GENSCRIPT BIOTECH : Controlling Shareholder Completes Disposal of Stake
MT
06/11GENSCRIPT BIOTECH : Issues 103 Million Shares to Hillhouse Capital; Stocks Slide..
MT
06/11Hillhouse Capital Management, Ltd. completed the acquisition of 2.99% stake i..
CI
06/02GENSCRIPT : Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensi..
PR
06/01GENSCRIPT BIOTECH : Grants Share Options, Restricted Shares; Shares Rally 5%
MT
05/28Genscript Biotech's Nasdaq-listed Unit Readies to Present Study Results of My..
MT
05/27US FDA to Prioritize Review of Genscript Biotech's Myeloma Drug
MT
05/25Genscript Biotech Corporation Updates on the Investigation by the Zhenjiang C..
CI
05/24Genscript Biotech Closes Sale of $300 Milion Worth of Legend Biotech Shares t..
MT
More news
News in other languages on GENSCRIPT BIOTECH CORPORATION

- No features available -

More news
Chart GENSCRIPT BIOTECH CORPORATION
Duration : Period :
Genscript Biotech Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 4,39 $
Average target price 3,30 $
Spread / Average Target -24,8%
EPS Revisions
Managers and Directors
Zhenyu Liu Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Chairman & Secretary
Hong Xin Guo Independent Non-Executive Director
Zu Mian Dai Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
GENSCRIPT BIOTECH CORPORATION202.30%9 200
MODERNA, INC.230.85%138 784
LONZA GROUP AG21.77%56 806
IQVIA HOLDINGS INC.38.25%47 656
CELLTRION, INC.-29.39%31 282
SEAGEN INC.-12.42%26 668